EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)

Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, Yuping Zhang, Noshad Hosseini, Ankur R Sangoi, Andres Acosta, Sean R Williamson, Somnath Mahapatra, Anya K Chinnaiyan, Jing Hu, Ulka Vaishampayan und 13 weitere

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Rahul Mannan und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, In Situ Hybridization, Fluorescence, Microphthalmia-Associated Transcription Factor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TFE3 and TFEB break-apart fluorescent in situ hybridization (FISH) assays are the "gold standard" for diagnostic confirmation of microphthalmia-associated transcription factor (MiTF) family-altered renal cell carcinoma (MiTF RCC), which includes TFE3-rearranged RCC and TFEB-altered RCC. However, FISH assays, for multiple reasons, may lead to equivocal or false-negative results, especially in cryptic fusions resulting from intrachromosomal inversions involving 5' partner genes, such as non-POU domain-containing octamer-binding protein (NONO); GRIPI-associated protein 1 (GRIPAP1); RNA-binding motif protein, X chromosome (RBMX); and RNA-binding motif protein 10 (RBM10). When FISH results are negative in cases with strong morphological suspicion of the listed tumor entities, pathologists may recommend targeted RT-PCR or panel-based RNA fusion sequencing for diagnostic confirmation. Our recent RNA in situ hybridization (RNA ISH)-based study demonstrated RNA expression of the tripartite motif containing 63 (TRIM63) to be highly enriched in TFE3-rearranged RCC and TFEB-altered RCC, including 2 FISH false-negative RCC cases harboring RBM10::TFE3 fusion. Based on these observations, we hypothesized that TRIM63 positivity could aid in diagnosing cases that are negative by conventional FISH assay but remain morphologically suspicious, representing an unmet clinical need in this area. We collected 20 RCC cases with morphological suspicion (with equivocal/indeterminate immunohistochemistry panel) of MiTF RCC, which were TRIM63 positive, negative/equivocal for TFE3/TFEB gene rearrangement by FISH, and underwent next-generation sequencing (NGS). On NGS correlation, 14 of 20 (70%) FISH-negative TRIM63-positive tumors harbored an MiTF gene rearrangement. In the remaining 6 cases, we were unable to fully ascertain the MiTF rearrangement status due to the inherent limitation of the NGS panel utilized. The cases with MiTF gene rearrangement include TFE3 rearrangement in 60% (12/20) and TFEB low-level copy gains (with an additional missense mutation in 1 case) in 10% (2/20) of samples. RBM10:TFE3 fusion was seen in 67% (8/12) of TFE3-rearranged RCC in this cohort. TRIM63 RNA ISH assay could aid in identifying cases that harbor TFE3 or TFEB rearrangement associated with false-negative or equivocal TFE3/TFEB FISH results, especially those involving gene fusions with a paracentric Xp11 inversion. Overall, employment of TRIM63 RNA ISH coupled with TFE3/TFEB FISH assays and follow-up genomic interrogation enhanced diagnostic accuracy for patients with MiTF RCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsIn Situ Hybridization, FluorescenceMicrophthalmia-Associated Transcription FactorUbiquitin-Protein LigasesTripartite Motif ProteinsMuscle ProteinsHumansFalse Negative ReactionsMaleFemaleYoung AdultAdultMiddle AgedAgedRNA, MessengerGene Expression ProfilingBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Stichwörter der Autor:innen

RNAamplificationbiomarkerfluorescent in situ hybridizationkidneymicrophthalmia-associated transcription factor family–altered renal cell carcin…

Substanzen

MITF protein, humanMicrophthalmia-Associated Transcription FactorUbiquitin-Protein LigasesTripartite Motif ProteinsTRIM63 protein, humanMuscle ProteinsRNA, MessengerTFE3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan; Michigan Center for Translational Pathology, Ann Arbor, Michigan.
  • Department of Pathology, Memorial Sloan Kettering, New York, New York.
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Pathology, School of Medicine, Stanford Medicine, California.
  • Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana.

Zitieren

APA

Mannan, R., Chen, Y. B., Wang, X., Zhang, Y., Hosseini, N., Sangoi, A. R., Acosta, A., Williamson, S. R., Mahapatra, S., Chinnaiyan, A. K., Hu, J., Vaishampayan, U., Shao, L., Betz, B. L., Kim, A. S., Cao, X., Su, F., Wang, R., Argani, P., …, & Mehra, R. (2025). TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC). Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100873

Vancouver

Mannan R, Chen YB, Wang X, Zhang Y, Hosseini N, Sangoi AR, et al. TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC). Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100873

BibTeX
@article{Mannan2025,
  author = {Mannan, Rahul and Chen, Ying-Bei and Wang, Xiaoming and Zhang, Yuping and Hosseini, Noshad and Sangoi, Ankur R and Acosta, Andres and Williamson, Sean R and Mahapatra, Somnath and Chinnaiyan, Anya K and Hu, Jing and Vaishampayan, Ulka and Shao, Lina and Betz, Bryan L and Kim, Annette S and Cao, Xuhong and Su, Fengyun and Wang, Rui and Argani, Pedram and Brown, Noah and Tickoo, Satish K and Chinnaiyan, Arul M and Reuter, Victor E and Dhanasekaran, Saravana M and Mehra, Rohit},
  title = {TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100873}
}
Kostenlos starten →